Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, ...

Launched nationwide by Novartis, Pluvicto intravenously delivers radioactive doses to prostate cancer cells—a huge step in ...

Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while ...

AstraZeneca's drug Truqap in combination with two other medications secured approval for the treatment of a form of advanced prostate cancer by the Food and Drug Administration. Approval was based on ...

There may be a "promising new strategy" in combating aggressive forms of prostate cancer, according to a new study. Researchers at Flinders University and the University of South Australia ...

She may still be his wife, but advanced prostate cancer can leave her feeling more like a nurse—and that painful shift is ...

Stereotactic ablative radiotherapy for prostate cancer treatment has been proven effective at five doses versus 20 with ...

AstraZeneca’s Truqap (capivasertib) gained FDA approval, combined with abiraterone and prednisone, for treatment of certain ...

orgovyx (relugolix) is a medicine used to treat advanced prostate cancer in adults. Advanced prostate cancer means that the cancer has spread outside of the prostate. Advanced cancers have often come ...

Thousands of men with prostate cancer will be offered a more targeted radiotherapy by the NHS which requires just five doses.

By Nancy Lapid June 3 (Reuters) - A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss ...

Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, fueling drug resistance and disease progression.